Clinical Site 103 — Boston, Massachusetts

Clinical Site 103 is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Site 103 has participated in 1 clinical trials.

Therapeutic areas: Adjunctive Treatment of Major Depressive Disorder.

Sponsors: Clexio Biosciences Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Site 103?

Clinical Site 103 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Site 103 conducted?

Clinical Site 103 has 1 clinical trials on record. Their work covers Adjunctive Treatment of Major Depressive Disorder.

Is Clinical Site 103 accredited by Crixeo Health?

Clinical Site 103 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Site 103?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.